Rare diseases
Investigational molecules
Locations
Back to Germany1 444 clinical trials in Hochheim Am Main, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study on Melphalan and Drug Combination for Low and Intermediate Risk Neuroblastoma Patients
GermanyEvaluation of Long-Term Efficacy and Safety of Obefazimod as Maintenance Therapy in Patients with Moderately to Severely Active Ulcerative Colitis
GermanyStudy of linaprazan glurate and lansoprazole to maintain healing in patients with erosive esophagitis caused by acid reflux disease
GermanyStudy on the Effectiveness and Safety of ESK-001 and Apremilast for Patients with Moderate to Severe Plaque Psoriasis
GermanyStudy of dupilumab added to inhaled corticosteroids and long-acting beta-agonists compared to high-dose inhaled therapy in adolescents and adults with uncontrolled asthma
GermanyOral Semaglutide in People With Mild Cognitive Impairment or Mild Dementia of the Alzheimer’s Type
GermanyStudy on Lorundrostat for Patients with Uncontrolled and Resistant Hypertension
GermanyEvaluation of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Type 2 Diabetes Patients with High Cardiovascular Risk
GermanyORKA-001 in Patients with Moderate-to-Severe Plaque Psoriasis
GermanyBaricitinib Compared with Adalimumab and Etanercept in Patients with Rheumatoid Arthritis
GermanyEfficacy and Safety of MET097 Once Weekly in People with Overweight or Obesity and Type 2 Diabetes
GermanyA study to evaluate the efficacy and safety of MET097 in people with obesity or overweight.
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on Gaucher disease and Niemann-Pick disease, exploring new therapeutic approaches for these challenging genetic conditions. Studies aim to evaluate novel treatments for improving neurological symptoms and overall patient outcomes.
Clinical investigations evaluating venglustat and nizubaglustat's effectiveness in managing disease progression.
Research centered on treating Mucopolysaccharidosis Type II (Hunter Syndrome) and Pompe disease, with multiple studies investigating innovative enzyme replacement therapies and novel drug combinations.
Evaluation of treatments like JR-141 and cipaglucosidase alfa for improved patient outcomes.
Studies focused on preventing respiratory syncytial virus infections in older adults, with particular attention to vaccine development and immune response assessment.
Investigation of revaccination strategies and long-term protection against respiratory infections.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
